These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29562465)

  • 1. [Impact on platelet recovery of recombinant human thrombopoietin in severe aplastic anemia patients with allogeneic hematopoietic stem cell transplantation].
    Song Y; Zhou F; Song NX; Liu XM; Yu Z; Xie LN; Song XC; Li X
    Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):207-211. PubMed ID: 29562465
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of Recombinant Human Thrombopoietin on Platelet Reconstitution after Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma].
    Xie Y; Yan LZ; You T; Shi XL; Yan S; Zhai YY; Shang JJ; Yan Z; You HY; Wang QQ; Wu DP; Fu CC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):505-511. PubMed ID: 38660859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Human Thrombopoietin Promotes Platelet Engraftment in Severe Aplastic Anemia Patients Following Treatment With Haploid Hematopoietic Stem Cell Transplantation using Modified Post-Transplantation Cyclophosphamide.
    Fu A; Peng Y; Cheng P; Wu J; Zhu X; Yang Y; Huang L; Wang N; Wang J; Xu J; Wan Y; Cao Y; Wei J; Xiao Y; Meng F; Cheng H; Zhang Y; Zhang D
    Transplant Cell Ther; 2024 May; 30(5):500-509. PubMed ID: 38447750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of rhTPO and rhIL-11 on Thrombocytopenia after Chemotherapy in Leukemia].
    Dai JF; Xia RX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):711-717. PubMed ID: 35680794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of Recombinant Human Thrombopoietin and Recombinant Human Interleukin 11 for Treatment of Chemotherapy Indu-ced Thrombocytopenia in Acute Myeloid Leukaemia Patients].
    Tang G; Wang XM; Meng JX; Luan CL; Chen JF; Wu YQ; Zhang XN; He ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):234-238. PubMed ID: 29397850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of recombinant human thrombopoietin (rhTPO) on short-term response of immunosuppressive therapy in patients with newly diagnosed acquired severe aplastic anemia].
    Zhang L; Yang W; Ye L; Zhou K; Jing L; Li Y; Li Y; Li J; Peng G; Song L; Zhao X; Wu Z; Zhang F
    Zhonghua Xue Ye Xue Za Zhi; 2015 Mar; 36(3):181-5. PubMed ID: 25854458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Human Thrombopoietin Promotes Platelet Engraftment and Improves Prognosis of Patients with Myelodysplastic Syndromes and Aplastic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation.
    Wang H; Huang M; Zhao Y; Qi JQ; Chen C; Tang YQ; Qiu HY; Fu CC; Tang XW; Wu DP; Ruan CG; Han Y
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1678-1684. PubMed ID: 28642072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human thrombopoietin treatment promotes hematopoiesis recovery in patients with severe aplastic anemia receiving immunosuppressive therapy.
    Wang H; Dong Q; Fu R; Qu W; Ruan E; Wang G; Liu H; Wu Y; Song J; Xing L; Guan J; Li L; Shao Z
    Biomed Res Int; 2015; 2015():597293. PubMed ID: 25861635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non-inferiority, randomized controlled trial.
    Wen B; Zhang X; Chen S; Fan J; Yang S; Cai Y; Wang P; Zhang Q; Gu Q; Du X
    Hematol Oncol; 2022 Oct; 40(4):777-786. PubMed ID: 35554955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the efficacy of cyclosporin A combined with recombined human thrombopoietin for treating patients with non-severe aplastic anemia].
    Zhang ML; Chen WS; Han B
    Zhonghua Xue Ye Xue Za Zhi; 2020 Aug; 41(8):637-642. PubMed ID: 32942816
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of c-mpl ligands after total body irradiation (TBI) with and without allogeneic hematopoietic stem cell transplantation: low-dose TBI does not prevent sensitization.
    Nash RA; Takatu A; Feng Z; Slichter S; Abrams K; Espino G; Gass MJ; Georges GE; McSweeney PA; Shulman HM; Storb R
    Biol Blood Marrow Transplant; 2002; 8(7):360-7. PubMed ID: 12171482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of efficacy and safety of two different dose of recombinant human thrombopoietin regimens in severe aplastic anemia patients with immunosuppressive therapy].
    Zhou K; Li Y; Li JP; Fan HH; Zhang L; Jing LP; Peng GX; Ye L; Li Y; Song L; Zhao X; Yang WR; Wu ZJ; Chen F; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):205-9. PubMed ID: 27033757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential treatment with rmIL-3 or simultaneous treatment with rmIL-3 or rhIL-11 with thrombopoietin (TPO) fails to enhance in vivo neonatal rat thrombocytopoiesis.
    van de Ven C; Fernandez GW; Herbst T; Knoppel A; Cairo MS
    Exp Hematol; 1997 Aug; 25(9):1005-12. PubMed ID: 9257814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel recombinant human thrombopoietin for treating prolonged isolated thrombocytopenia after allogeneic stem cell transplantation.
    Sun YQ; Kong Y; Zhang XH; Wang Y; Shi MM; Song Y; Kong J; Fu HX; Yan CH; Xu LP; Liu KY; Huang XJ
    Platelets; 2019; 30(8):994-1000. PubMed ID: 30569802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial.
    Han TT; Xu LP; Liu DH; Liu KY; Wang FR; Wang Y; Yan CH; Chen YH; Sun YQ; Ji Y; Wang JZ; Zhang XH; Huang XJ
    Ann Hematol; 2015 Jan; 94(1):117-28. PubMed ID: 25069650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Recombinant Human Thrombopoietin for the Treatment of Secondary Failure of Platelet Recovery After Allogeneic HSCT.
    Cao Y; Wang M; Shen B; Zhao F; Zhang R; Chen X; He Y; Zhai W; Ma Q; Wei J; Huang Y; Yang D; Pang A; Feng S; Jiang E; Han M
    Clin Appl Thromb Hemost; 2022; 28():10760296211068037. PubMed ID: 35019756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation.
    Nash RA; Kurzrock R; DiPersio J; Vose J; Linker C; Maharaj D; Nademanee AP; Negrin R; Nimer S; Shulman H; Ashby M; Jones D; Appelbaum FR; Champlin R
    Biol Blood Marrow Transplant; 2000; 6(1):25-34. PubMed ID: 10707996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human thrombopoietin improved platelet engraftment after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.
    Gu J; Liu J; Li X; Zou W; Huang B; Chen M; Li J
    Cancer Med; 2021 Nov; 10(21):7641-7649. PubMed ID: 34569193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study.
    Chen M; Li L; Xia Q; Chen X; Liao Z; Wang C; Shen B; Zhou M; Zhang Q; Zhang Y; Qian L; Yuan X; Wang Z; Xue C; An X; Liu B; Gu K; Hou M; Wang X; Wang W; Li E; Zhong J; Cheng J; Shu Y; Yang N; Wang H; Yang R; Liu T; Deng T; Ma F; Liao W; Qiu W; Chen Y; Chen X; Zhang M; Xu R; Li X; Feng J; Ba Y; Shi Y
    Cancer; 2024 Apr; 130(S8):1524-1538. PubMed ID: 38515388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.